Interaction Color Code
Clinical Bottom Line
Do not coadminister: Potential for reduced levels of glecaprevir / Pibrentasvir
Drug 1
Drug 2
Drug 2 effect
Not studied (may decrease grazprevir levels)
Clinical Effects
Potentially decreased glecaprevir / pibrentasvir levels expected
Management
Avoid combination. Use alternative agents
Import ID
546
